NCT03436511View on ClinicalTrials.gov

Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL
Enrollment

341

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

December 10, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (4)

28040

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

46017

GSK Investigational Site, Valencia

08036

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators (1)

Oblikue Consulting
All Listed Sponsors
collaborator

Oblikue Consulting

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY